Abstract
Left Ventricular Non-Compaction (LVNC) is a relatively rare (0.3% prevalence) cardiac condition, characterised by prominent trabeculations and deep recesses of the endomyocardial tissue of the left ventricle. LVNC may be congenital or acquired and is thought to be reversible with changes in cardiac preload. Athletes and pregnant women have been shown to demonstrate features of left ventricular (LV) hypertrabeculation suggesting that, in low risk cohorts, LVNC may simply be a result of increased cardiac preload. Athletic individuals are usually asymptomatic and are often diagnosed incidentally during routine imaging evaluation. However, currently there is no gold standard for the diagnosis of LVNC, and existing echocardiographic diagnostic criteria is based on the ratio of compacted versus non-compacted LV myocardium on echocardiography and vary in terms of measurements in end-diastole or end-systole. Similarly, there are also cardiac magnetic resonance imaging criteria available for diagnosis. As a high proportion of athletes meet the criteria for a diagnosis of LVNC, without exhibiting other clinical features of the disorder and in the absence of a positive family history, it may be that increased LV trabeculations are of limited significance in this group and simply form part of the ‘athlete’s heart’. The presence of LV hypertrabeculation in asymptomatic athletes in the absence of a family history does not require further evaluation. Athletes with an unequivocal diagnosis of LVNC should be advised to participate in leisure activities only and be closely monitored. The echocardiographic and cardiac MRI diagnostic criteria for LVNC is based on small cohorts and is not ethnically diverse, risking overdiagnosis in some populations. Clearer diagnostic criteria, modified for ethnicity, is required. There is a poor genotype and phenotype correlation, so it is important to look at the overall clinical picture. However, prognosis of LVNC in low risk cohorts remains good.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gati S, Rajani R, Carr-White GS, Chambers JB. Adult left ventricular noncompaction: reappraisal of current diagnostic imaging modalities. JACC Cardiovasc Imaging. 2014;7(12):1266–75.
Gati S, Merghani A, Sharma S. Increased left ventricular trabeculation does not necessarily equate to left ventricular noncompaction in athletes left ventricular noncompaction in athletes letters. JAMA Intern Med. 2015;175(3):461–2.
Gati S, Chandra N, Bennett RL, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart. 2013;99(6):401–8.
Gati S, Papadakis M, Papamichael ND, et al. Reversible de novo left ventricular trabeculations in pregnant women: Implications for the diagnosis of left ventricular noncompaction in low-risk populations. Circulation. 2014;130(6):475–83.
Gati S, Papadakis M, Van Niekerk N, Reed M, Yeghen T, Sharma S. Increased left ventricular trabeculation in individuals with sickle cell anaemia: physiology or pathology? Int J Cardiol. 2013;168(2)
Caselli S, Attenhofer Jost CH, Jenni R, Pelliccia A. Left ventricular noncompaction diagnosis and management relevant to pre-participation screening of athletes. Am J Cardiol. 2015;116(5):801–8.
Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the sport cardiology section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2018;40(1):19–33.
Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH. Developmental patterning of the myocardium. Anat Rec. 2000;258(4):319–37.
Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86(6):666–71.
Boyd MT, Seward JB, Tajik AJ, Facc WDE. Morphologic studies frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography. J Am Coll Cardiol. 1987;9(2):323–6.
Arbustini E, Favalli V, Narula N, Serio A, Grasso M. Left ventricular noncompaction: a distinct genetic cardiomyopathy? J Am Coll Cardiol. 2016;68(9):949–66.
van Waning JI, Caliskan K, Hoedemaekers YM, et al. Genetics, clinical features, and long-term outcome of noncompaction cardiomyopathy. J Am Coll Cardiol. 2018;71(7):711 LP–722.
Oechslin EN, Jost CHA, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36(2):493–500.
Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997;72(1):26–31.
Oechslin E, Jenni R. Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity? Eur Heart J. 2011;32(12):1446–56.
Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J. 2008;29(1):89–95.
Hutchins IM, Schaefer S. Progressive left ventricular noncompaction and systolic dysfunction. Exp Clin Cardiol. 2012;17(2):81–3.
Bleyl SB, Mumford BR, Brown-Harrison MC, et al. Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet. 1997;72(3):257–65.
Frischknecht BS, Attenhofer Jost CH, Oechslin EN, et al. Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Soc Echocardiogr. 2005;18(8):865–72.
Markovic NS, Dimkovic N, Damjanovic T, Loncar G, Dimkovic S. Isolated ventricular noncompaction in patients with chronic renal failure. Clin Nephrol. 2008;70(1):72–6.
Stollberger C, Gerecke B, Finsterer J, Engberding R. Refinement of echocardiographic criteria for left ventricular noncompaction. Int J Cardiol. 2013;165(3):463–7.
Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990;82(2):507–13.
Captur G, Muthurangu V, Cook C, et al. Quantification of left ventricular trabeculae using fractal analysis. J Cardiovasc Magn Reson. 2013;15(1):36.
Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46(1):101–5.
Jacquier A, Thuny F, Jop B, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J. 2010;31(9):1098–104.
Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol. 2002;90(8):899–902.
Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr. 2004;17(1):91–100.
Bellavia D, Michelena HI, Martinez M, et al. Speckle myocardial imaging modalities for early detection of myocardial impairment in isolated left ventricular non-compaction. Heart. 2010;96(6):440–7.
Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail. 2011;13(2):170–6.
Kawel N, Nacif M, Arai AE, et al. Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2012;5(3):357–66.
Assuncao AN Jr, Nomura CH, Parga JR, et al. Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy. Eur Hear J Cardiovasc Imaging. 2018;19(8):888–95.
Sharma S, Merghani A, Mont L. Exercise and the heart: the good, the bad, and the ugly. Eur Heart J. 2015;36(23):1445–53.
Caselli S, Ferreira D, Kanawati E, et al. Prominent left ventricular trabeculations in competitive athletes: a proposal for risk stratification and management. Int J Cardiol. 2016;223:590–5.
Abela M, D’Silva A. Left ventricular trabeculations in athletes: epiphenomenon or phenotype of disease? Curr Treat Options Cardiovasc Med. 2018;20(12):100.
Pelliccia A. Differences in cardiac remodeling associated with race implications for pre-participation screening and the unfavorable situation of black athletes. J Am Coll Cardiol. 2008;51(23):2263–5.
Thavendiranathan P, Dahiya A, Phelan D, Desai MY, Tang WHW. Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes and management. Heart. 2013;99(10):681–9.
Greutmann M, Mah ML, Silversides CK, et al. Predictors of adverse outcome in adolescents and adults with isolated left ventricular noncompaction. Am J Cardiol. 2012;109(2):276–81.
Lofiego C, Biagini E, Pasquale F, et al. Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart. 2007;93(1):65–71.
Habib G, Charron P, Eicher J-C, et al. Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry. Eur J Heart Fail. 2011;13(2):177–85.
Stanton C, Bruce C, Connolly H, et al. Isolated left ventricular noncompaction syndrome. AJC. 2009;104(8):1135–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Clinical Application
Clinical Application
1.1 Questions
-
1.
A 17-year-old male, Caucasian, competitive rower is found to have features of LVNC on cardiac MRI, following a private health screening. He has no family history of cardiac disease or sudden cardiac death. His electrocardiogram is normal, and an echocardiogram shows an ejection fraction of 50% and normal LV function. What is the diagnosis, and can he continue to compete in his chosen sport?
-
2.
A 23-year-old male, Afro-Caribbean, professional football player presents with syncopal episodes, shortness of breath on exertion and palpitations. His maternal Grandmother died aged 46 in unclear circumstances. His electrocardiogram shows deep inferolateral T-wave inversion. His echocardiogram shows an ejection fraction of 43% and normal LV function. A cardiac MRI shows features of mild myocardial non-compaction. What further tests would you order and how would you manage this patient?
-
3.
A 34-year-old female, Caucasian, air race pilot has an annual health check as requested by her insurance company. She is asymptomatic apart from a recent bad cold. Her latest electrocardiogram shows ST depression. An echocardiogram shows an ejection fraction of 49% and normal LV dimensions and function. Cardiac MRI shows evidence of myocardial non-compaction. Ambulatory monitoring and an exercise electrocardiogram show no arrhythmias and no episodes of non-sustained VT. Can she compete in the air show this weekend?
1.2 Answers
-
1.
Although this young athlete has a feature of LVNC on imaging, in the absence of symptoms, positive family history, abnormal ECG patterns and, most importantly, impaired LV function, he has no restriction for any competitive sports.
-
2.
This patient is symptomatic with concerning features on electrocardiogram and cardiac MRI. He should undergo further testing: an exercise stress test and peak exercise echocardiogram and should refrain from competitive sport until a diagnosis has been confirmed.
-
3.
This air race pilot should not compete in the air show this weekend and should refrain from further air races. She is asymptomatic with no prior history of unexplained syncope and has no complex ventricular arrhythmias or episodes of non-sustained VT. She may compete in all competitive sports except those where occurrence of syncope may cause serious harm or death to herself or others. She should be encouraged to consider a ground sport if she wishes to continue competing.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sedgwick, C., Gati, S. (2020). Specific Cardiovascular Diseases and Competitive Sports Participation: Left Ventricular Hypertrabeculation. In: Pressler, A., Niebauer, J. (eds) Textbook of Sports and Exercise Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-35374-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-35374-2_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35373-5
Online ISBN: 978-3-030-35374-2
eBook Packages: MedicineMedicine (R0)